GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (XPAR:VIRP) » Definitions » Construction In Progress

Virbac (XPAR:VIRP) Construction In Progress : €21 Mil (As of Jun. 2023)


View and export this data going back to 1989. Start your Free Trial

What is Virbac Construction In Progress?

Virbac's quarterly construction in progress declined from Jun. 2022 (€36 Mil) to Dec. 2022 (€27 Mil) and declined from Dec. 2022 (€27 Mil) to Jun. 2023 (€21 Mil).

Virbac's annual construction in progress increased from Dec. 2020 (€19 Mil) to Dec. 2021 (€28 Mil) but then declined from Dec. 2021 (€28 Mil) to Dec. 2022 (€27 Mil).


Virbac Construction In Progress Historical Data

The historical data trend for Virbac's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Construction In Progress Chart

Virbac Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.80 12.48 18.53 28.29 26.60

Virbac Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.89 28.29 35.98 26.60 20.90

Virbac Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Virbac (XPAR:VIRP) Business Description

Traded in Other Exchanges
Address
2065m LID, 1 ere avenue, Carros, FRA, 06516
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.

Virbac (XPAR:VIRP) Headlines

No Headlines